title: Severe persistent asthma responsive to off-label use of omalizumab despite high and low levels of total serum IgE.
authors: Nobuhiro
authors: N
authors: Asai
authors: Yoshihiro
authors: Y
authors: Ohkuni
authors: Akina
authors: A
authors: Komatsu
authors: Ryo
authors: R
authors: Matsunuma
authors: Kei
authors: K
authors: Nakashima
authors: Norihiro
authors: N
authors: Kaneko
mesh_terms: D000368:Aged; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D008875:Middle Aged; D056687:Off-Label Use; D000069444:Omalizumab
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E